Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Lamija Hindija"'
Autor:
Ognjenka Rahić, Amina Tucak-Smajić, Merima Šahinović, Belma Imamović, Lamija Hindija, Jasmina Hadžiabdić, Edina Vranić
Publikováno v:
Kemija u Industriji, Vol 73, Iss 5-6, Pp 215-220 (2024)
Paediatric and geriatric populations, as well as other special patient populations with swallowing problems, require patient-tailored dosage forms. One promising dosage form for these specific populations is orodispersible films. When preparing orod
Externí odkaz:
https://doaj.org/article/b3b8ed5a33ae4d43aeeefff573121cb3
Autor:
Lamija Hindija, Jasmina Hadžiabdić, Anja Haverić, Ognjenka Rahić, Maida Hadžić Omanović, Lejla Čaluk Klačar, Irma Durmišević, Amina Tucak Smajić, Merima Šahinović, Edina Vranić
Publikováno v:
Biomolecules & Biomedicine (2024)
Dimenhydrinate (DMH), used to alleviate motion sickness symptoms such as nausea, vomiting, dizziness, and vertigo, encounters limitations in oral pharmaceutical formulations due to its poor water solubility and bitter taste. Our research hypothesized
Externí odkaz:
https://doaj.org/article/88467bcfef2048da96a19706fe7ab829
Publikováno v:
J, Vol 4, Iss 1, Pp 62-81 (2021)
Although homeostasis is a commonly accepted concept, there is incontrovertible evidence that biological processes and functions are variable and that variability occurs in cycles. In order to explain and understand dysregulation, which has not been e
Externí odkaz:
https://doaj.org/article/1bf8efd8a397408d9b6882222fc76760
Autor:
Merima Sirbubalo, Amina Tucak, Kenan Muhamedagic, Lamija Hindija, Ognjenka Rahić, Jasmina Hadžiabdić, Ahmet Cekic, Derzija Begic-Hajdarevic, Maida Cohodar Husic, Almir Dervišević, Edina Vranić
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 924 (2021)
Microneedles (MNs) represent the concept of attractive, minimally invasive puncture devices of micron-sized dimensions that penetrate the skin painlessly and thus facilitate the transdermal administration of a wide range of active substances. MNs hav
Externí odkaz:
https://doaj.org/article/e9f501651d3e43d5881ddea68cb12bbc
Autor:
Ognjenka Rahić, Amina Tucak, Naida Omerović, Merima Sirbubalo, Lamija Hindija, Jasmina Hadžiabdić, Edina Vranić
Publikováno v:
Pharmaceutics, Vol 13, Iss 1, p 28 (2020)
Glaucoma is considered to be one of the biggest health problems in the world. It is the main cause of preventable blindness due to its asymptomatic nature in the early stages on the one hand and patients’ non-adherence on the other. There are sever
Externí odkaz:
https://doaj.org/article/44bc4683d3824e52a2bc56309bb197a5
Autor:
Amina Tucak, Merima Sirbubalo, Lamija Hindija, Ognjenka Rahić, Jasmina Hadžiabdić, Kenan Muhamedagić, Ahmet Čekić, Edina Vranić
Publikováno v:
Micromachines, Vol 11, Iss 11, p 961 (2020)
Although transdermal drug delivery systems (DDS) offer numerous benefits for patients, including the avoidance of both gastric irritation and first-pass metabolism effect, as well as improved patient compliance, only a limited number of active pharma
Externí odkaz:
https://doaj.org/article/0c3cce243f884d32b0991705980a9d9b
Autor:
Ognjenka, Rahić, Jasmina, Hadžiabdić, Amina, Tucak, Merima, Sirbubalo, Lamija, Hindija, Alisa, Elezović, Edina, Vranić
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE To examine the influence of vehicles on the stability of extemporaneous suspensions of proton pump inhibitors (PPIs), to single out the formulation most suitable for children, providing appropriate evidence and arguments. METHODS A review w
Autor:
Jasmina Hadžiabdić, Almina Šećkanović, Ognjenka Rahić, Lamija Hindija, Merima Sirbubalo, Amina Tucak-Smajić, Marija Glavaš-Dodov, Edina Vranić
Publikováno v:
Macedonian Pharmaceutical Bulletin. 68:285-286
Autor:
Ognjenka Rahić, Jasmina Hadžiabdić, Amina Tucak-Smajić, Merima Sirbubalo, Lamija Hindija, Marija Glavaš-Dodov, Edina Vranić
Publikováno v:
Macedonian Pharmaceutical Bulletin. 68:283-284
Autor:
Ognjenka Rahić, Jasmina Hadžiabdić, Amina Tucak, Lamija Hindija, Edina Vranić, Merima Sirbubalo
Publikováno v:
Ophthalmology Research: An International Journal. :17-33
Since glaucoma is a serious health problem, numerous therapeutics are being developed to reduce Intraocular Pressure (IOP) as the only modifiable factor of all glaucoma symptoms. IOP-lowering agents are divided into six groups, each of which has a sp